Cost effectiveness of Yokukansan for BPSD(behavioral and psychologicalsymptoms of dementia) in Mild to Moderate Alzheimer's disease and Dementia with Lewy bodies.

Cost effectiveness of Yokukansan for BPSD(behavioral and psychologicalsymptoms of dementia) in Mild to Moderate Alzheimer's disease and Dementia with Lewy bodies. - Cost effectiveness of Yokukansan for BPSD in Mild to Moderate AD and DLB.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020374

Enrollment

100

Registered

2016-01-12

Start date

2016-01-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&amp

Interventions

admistration of Yokukansan Tsumura yokukansan granules 2.5g three times a day , administered during the test period Non admistration of Yokukansan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: It satisfies a diagnosis of dementia in DSM-5, dementia due to Alzheimer&#39;s disease, among those diagnosed with dementia with Lewy body disease, those with a neurosis or insomnia. Neuropsychiatric Inventory subscale or more 6

Exclusion criteria

Exclusion criteria: Patients with a history of hypersensitivity to components of the yokukansan

Design outcomes

Primary

Measure	Time frame
QALY (quality adjusted life year),The Change of Cost (direct cost, indirect cost) of yokukansan administration group and the non-administration group of before and after therapy Evaluation time : the time of introduction , 4 weeks , 12-14 weeks , 24-26 weeks , 52-54 weeks	—

Secondary

Measure	Time frame
NPI(Neuropsychiatric Inventory),MMSE(mini mental state exam)	—

Countries

Japan

Contacts

Public ContactTsuyoshi Noda

Tokyo Women's Medical University East Medical Center Psychiatry

noda1976@gmail.com080-4425-3143

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Cost effectiveness of Yokukansan for BPSD(behavioral and psychologicalsymptoms of dementia) in Mild to Moderate Alzheimer&#39;s disease and Dementia with Lewy bodies.